Infinity Pharmaceuticals (NASDAQ:INFI) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Infinity Pharmaceuticals beat estimated earnings by 13.33%, reporting an EPS of $-0.13 versus an estimate of $-0.15.
Revenue was up $174 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 4.07% drop in the share price the next day.
Here's a look at Infinity Pharmaceuticals's past performance:
To track all earnings releases for Infinity Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
